Hence, IL7R signalling drives ROS production and redox dysfunction through the activation of PI3K/Akt/mTOR, JAK/STAT and ERK/MAPK pathways, all of which are implicated in ALL disease progression and treatment resistance [133,134,135]. The gene discussed is SOAT1; the disease is acute lymphoblastic leukemia.